Mayur Mansukhlal Doshi
Independent DirectorMr. Mayur Mansukhlal Doshi serves as Director of Scienture Holdings, Inc since May 28, 2024. He is Independent Director of PowerUp Acquisition Corp. from August 18, 2023. He is a director of Saptalis Pharmaceuticals. He serves as Independent Director of Crown Reserve Acquisition Corp. I since September 26, 2025. Mr. Doshi is President and CEO of Alfagene Bioscience, Inc. He has successfully initiated several companies and for the last ten years has been the CEO of Apogee Pharma. He has of experience in the global generic pharmaceutical market. He is a trained chemist and seasoned entrepreneur with extensive experience in active pharmaceutical ingredients. He has Pharmaceutical and Bio tech industry experience; entering the generic pharmaceutical industry in 1988. He is Chairman and Managing Director of Apogee Pharma, Inc., He works closely with his clients assisting them in bringing new generic drugs to market, including Barr Pharmaceuticals, DuPont Pharmaceuticals, Sandoz, Wyeth and Watson. He is also a major investor in a generic pharmaceutical company and is the founder and primary investor in, AlfaGene. He worked and managed extensively in the Pharmaceutical industry and created a multimillion dollar company. Mr. Doshi also serves as a philanthropist for various organizations. He received a Master’s in Chemical Engineering from Manhattan College.
公司職務
- 公司名稱Crown Reserve Acquisition Corp. I股票代碼CRAC職務Independent Director關聯證券
- 公司名稱Scienture Holdings, Inc.股票代碼SCNX職務Independent Director共事同僚
- SHShankar HariharanFounder, Co-CEO & Executive Chairman
- NMNarasimhan ManiPresident, Co-CEO, Interim CFO & Director
- RSRahul SuranaExecutive VP & COO of Scienture LLC
- MRMichele RathSenior VP & Chief Commercial Officer of Scienture LLC
- DGDonald G. FellIndependent Director
- SKSuneel K. GuptaMember of Scientific Advisory Board
